Abstract Ovarian cancer is the most lethal gynecologic malignancy, characterized by a poor five-year survival rate for patients with advanced-stage disease. EV-S008, an escin derivative, exhibits potent anti-ovarian cancer activity; however, its preclinical development has been hindered by inefficient synthetic methodologies. In this study, we report a rational, seven-step synthetic route for EV-S008 that achieves a 40-fold increase in yield and produces material with 99.3% p

前美國 FDA 仿製藥辦公室總監 陳桂恒博士 蒞臨指導

詹建強博士受邀到訪夏娃，與夏娃團隊討論紅三葉專案開發和業務發展戰略事宜

紅三葉草（Trifolium pratense L.），又名紅車軸草，爲豆科多年生草本植物，原産于歐洲和西亞，現廣泛分布于世界各地，爲溫帶分布植物，中國南北各地均有野生及栽培。紅三葉在國外有數百年的使用歷史，大約于20世紀20年代傳入我國，普遍用作牧草、飼料添加及園林景觀；...